companydata.dkZYMENEX ApS: Financial statements 2014
CVR: 27394752
ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -67,882,459 and a net result of DKK 1,065,781 compared with DKK -33,757,937 the year before. Equity amounted to DKK -64,755,985.
- Gross Profit
- -67,882,459 kr.
- Profit/Loss
- 1,065,781 kr.
- Equity
- -64,755,985 kr.
- Total Assets
- 18,486,107 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -67.9 mio. | 1.1 mio. | -64.8 mio. | - |
| 2013 | - | - | -33.8 mio. | -65.8 mio. | - |
| 2012 | - | - | -42 mio. | -32.1 mio. | - |
Keep an eye on ZYMENEX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
ZYMENEX ApS has published its annual report for 2013. The net result was DKK -33,757,937.
As of May 28, 2014, KPMG P/S has been appointed auditor of ZYMENEX ApS.
As of May 28, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ZYMENEX ApS.
As of May 28, 2014, Danilo Piroli has joined the board of directors of ZYMENEX ApS.
As of May 28, 2014, Paolo Patri has left the board of directors of ZYMENEX ApS.
As of May 28, 2014, Mark Parry-Billings is registered as chairman of ZYMENEX ApS.
As of May 28, 2014, Andrew Philip Dickinson has stepped down as chairman of ZYMENEX ApS.
About ZYMENEX ApS
ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.